Wissenschaftliche Veröffentlichungen

Publikationen über PubMed unter Brookman-May S und Brookman-Amissah S

1.       Campi R, Brookman-May SD, Subiela Henríquez JD, Akdoğan B, Brausi M, Klatte T, Langenhuijsen JF, Linares-Espinos E, Marszalek M, Roupret M, Stief CG, Volpe A, Minervini A, Rodriguez-Faba O.Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology. Eur Urol Focus. 2018 Apr 13. pii: S2405-4569(18)30090-7. doi: 10.1016/j.euf.2018.04.001.

2.       Rieken M, Kluth LA, Fajkovic H, Capitanio U, Briganti A, Krabbe LM, Margulis V, Abufaraj M, Mari A, Foerster B, Raman JD, Regelman M, Brookman-May S, Sjoberg DD, Karakiewicz PI, Shariat SF. Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence. Clin Genitourin Cancer. 2018 Mar 24. pii: S1558-7673(18)30212-X. doi: 10.1016/j.clgc.2018.03.003

3.       Aly M, Hashim M, Heeg B, Liwing J, Leval A, Mehra M, Lawson J, Brookman-May SD, Akre O. Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer-A Systematic Literature Review and Pooling of Individual Participant Data. Eur Urol Focus. 2018 Apr 4. pii: S2405-4569(18)30088-9. doi: 10.1016/j.euf.2018.03.010

4.       Brookman-May SD, Campi R, Henríquez JSD, Klatte T, Langenhuijsen JF, Brausi M, Linares-Espinós E, Volpe A, Marszalek M, Akdogan B, Roll C, Stief CG, Rodriguez-Faba O, Minervini A. Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU). Eur Urol Focus. 2018 Mar 22. pii: S2405-4569(18)30069-5. doi: 10.1016/j.euf.2018.02.007

5.       May M, Fritsche HM, Gilfrich C, Dombrowski, Maurer O, Spachmann P, Ganesh Kumar M, Bjurlin M, Burger M, Brookman-May S. What do patients with urothelial cancer know about the association of their tumor disease with smoking habits? Results of a German survey study. Investig Clin Urol. 2018 Mar;59(2):91-97. doi: 10.4111/icu.2018.59.2.91. Epub 2018 Feb 28

6.       May M, Brookman-May SD, Ecke TH, Burger M. [Molecular characterization of penile cancer: Literature review of new prognostic markers and potential therapeutic targets]. Urologe A. 2018 Feb 22. doi: 10.1007/s00120-018-0596-4

7.       Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M. Re: Letter to the editor. Int Urol Nephrol. 2018 Feb 13. doi: 10.1007/s11255-018-1808-y

8.       Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A; PROMETRICS 2011 Study Group. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 2018 Jan;121(1):101-110 – pubmed-gelistet als Kollaborator

9.       Roiner M, Maurer O, Lebentrau S, Gilfrich C, Schäfer C, Haberl C, Brookman-May SD, Burger M, May M, Hakenberg OW. [Management of penile cancer patients: new aspects of a rare tumour entity]. Aktuelle Urol. 2017 Dec 13. doi: 10.1055/s-0043-121223

10.   Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urol Oncol. 2017 Dec 5. pii: S1078-1439(17)30596-3. doi: 10.1016/j.urolonc.2017.11.011

11.   Miller K, Carles J, Gschwend JE, Van Poppel H, Diels J, Brookman-May SD. The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score. Eur Urol. 2017 Sep 20. pii: S0302-2838(17)30728-5. doi: 10.1016/j.eururo.2017.08.035

12.   Wagener N, Edelmann D, Benner A, Zigeuner R, Borgmann H, Wolff I, Krabbe LM, Musquera M, Dell’Oglio P, Capitanio U, Klatte T, Cindolo L, May M, Brookman-May SD; European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease. PLoS One. 2017 Sep 21;12(9):e0184173. doi: 10.1371/journal.pone.0184173. eCollection 2017

13.   Borgmann H, Musquera M, Haferkamp A, Vilaseca A, Klatte T, Shariat SF, Scavuzzo A, Jimenez Rios MA, Wolff I, Capitanio U, Dell’Oglio P, Krabbe LM, Herrmann E, Ecke T, Vergho D, Huck N, Wagener N, Pahernik S, Zastrow S, Wirth M, Surcel C, Mirvald C, Prochazkova K, Hutterer G, Zigeuner R, Cindolo L, Hora M, Stief CG, May M, Brookman-May SD. Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients. World J Urol. 2017 Dec;35(12):1891-1897

14.   Wolff I, Scavuzzo A, Capitanio U, Klatte T, Shariat SF, Wagener N, Zastrow S, Borgmann H, Krabbe LM, Hutterer G, May M, Brookman-May SD; Collaborative Research On Renal Neoplasms Association (CORONA) and the European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group. Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study. Urology. 2017 Nov;109:107-114

15.   Capitanio U, Stewart GD, Larcher A, Ouzaid I, Akdogan B, Roscigno M, Marszalek M, Dell’Oglio P, Salagierski M, Volpe A, Mir MC, Kriegmair M, Terrone C, Brookman-May SD, Montorsi F, Klatte T; Kidney Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU). European temporal trends in the use of lymph node dissection in patients with renal cancer. Eur J Surg Oncol. 2017 Nov;43(11):2184-2192

16.   Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell’Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy? Eur Urol Focus. 2017 Mar 21. pii: S2405-4569(17)30068-8. doi: 10.1016/j.euf.2017.02.020. [Epub ahead of print]

17.   Faba OR, Brookman-May SD, Linares E, Breda A, Pisano F, Subiela JD, Sanguedolce F, Brausi M, Palou J. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review. World J Urol. 2017 Dec;35(12):1807-1816. doi: 10.1007/s00345-017-2072-y. Epub 2017 Jul 12

18.   May M, Spachmann PJ, Lebentrau S, Schumacher H, Gilfrich C, Fritsche HM, Vetterlein M, Brookman-May S, Schostak M, Wagenlehner FM, Burger M, Novotny A, Obermaier R. [Do General Surgeons Feel Adequately Prepared for the Complex Questions Associated with the Handling of Multi-Resistant Pathogens? – Results of the MR2 Survey]. Zentralbl Chir. 2017 Jun;142(3):297-305

19.   May M, Vetterlein MW, Wagenlehner FM, Brookman-May SD, Gilfrich C, Fritsche HM, Spachmann PJ, Burger M, Schostak M, Lebentrau S; MR2-Studiengruppe. What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? An interdisciplinary analysis among German clinicians and development of a decision tool for urologists]. Urologe A. 2017 Oct;56(10):1302-1310

20.   Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 study group. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort. Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817 – pubmed-gelistet als Kollaborator

21.   May M, Obermaier R, Novotny A, Wagenlehner FM, Brookman-May SD. Face to Face with Multi-Resistant Pathogens: An Urgent Call to Action for Modern Surgeons To Pioneer in Antibiotic Stewardship. Surg Infect (Larchmt). 2017 Jul;18(5):645-646

22.   Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M; MR2 study group. Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol. 2017 Aug;49(8):1311-1318

23.   May M, Surcel C, Capitanio U, Dell’Oglio P, Klatte T, Shariat S, Ecke T, Wolff I, Vergho D, Wagener N, Huck N, Pahernik S, Zastrow S, Wirth M, Borgmann H, Haferkamp A, Musquera M, Krabbe LM, Herrmann E, Scavuzzo A, Mirvald C, Hutterer G, Zigeuner R, Stief CG, Waidelich R, Cindolo L, Kalusova K, Brookman-May SD; Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project). Scand J Urol. 2017 Aug;51(4):269-276

24.   May M, Lebentrau S, Brookman-May SD. Re: Decreased Overall and Bladder Cancer-specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis. Eur Urol. 2017 Jul;72(1):155-156

25.   May M, Stief CG, Brookman-May SD. Re: The Role of Adjuvant Radiotherapy in Pathologically Lymph Node Positive Prostate Cancer. Eur Urol. 2017 May;71(5):833-834

26.   May M, Maurer O, Lebentrau S, Brookman-May S. Lower use of prostate specific antigen testing by cigarette smokers-Another possible explanation for the unfavorable prostate cancer (PCA) specific prognosis in smokers? Cancer Epidemiol. 2017 Feb;46:34-35

27.   Brookman-May SD, May M, Lebentrau S, Klotz T. Re: Scott P. Kelly, Philip S. Rosenberg, William F. Anderson, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol 2017;71:195-201. Eur Urol. 2017 May;71(5):e145-e146

28.   May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P, Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg OW; PROMETRICS 2011 Research Group. Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database. Int Urol Nephrol. 2017 Feb;49(2):247-254

29.   Simone G, De Nunzio C, Ferriero M, Cindolo L, Brookman-May S, Papalia R, Sperduti I, Collura D, Leonardo C, Anceschi U, Tuderti G, Misuraca L, Dalpiaz O, Hatzl S, Lodde M, Trenti E, Pastore AL, Palleschi G, Lotrecchiano G, Salzano L, Carbone A, De Cobelli O, Tubaro A, Schips L, Zigeuner R, Tostain J, May M, Guaglianone S, Muto G, Gallucci M. Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset. Eur J Surg Oncol. 2016 Nov;42(11):1729-1735

30.   May M, Gilfrich C, Spachmann P, Maurer O, Dombrowski MK, Fritsche HM, Wöhr M, Brookman-May S, Karl T, Schostak M, Burger M, Lebentrau S. [What do prostate cancer patients know about smoking? : Results of a bicentric questionnaire study (KRAUT study)]. Urologe A. 2016 Aug;55(8):1078-85

31.   May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A, Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May SD; PROMETRICS 2011 Research Group. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011. World J Urol. 2017 Feb;35(2):245-250

32.   Wolff I, May M, Hoschke B, Zigeuner R, Cindolo L, Hutterer G, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin MD, Salzano L, Lotrecchiano G, Shariat SF, Hohenfellner M, Waidelich R, Stief C, Miller K, Pahernik S, Brookman-May S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group. Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database. Eur J Surg Oncol. 2016 May;42(5):744-50

33.   Rodriguez Faba O, Akdogan B, Marszalek M, Langenhuijsen JF, Brookman-May S, Stewart GD, Capitanio U, Sanguedolce F; Renal Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU). Current Status of Focal Cryoablation for Small Renal Masses. Urology. 2016 Apr;90:9-15

34.   Brookman-May S, Shariat SF, May M. Reply to Marco Borghesi, Gaetano La Manna, and Riccardo Schiavina’s Letter to the Editor re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943-51. Eur Urol. 2016 May;69(5):e101-2

35.   Ahmed A, Eckerl M, Bründl J, Peter J, Lebentrau S, Brookman-May S, Fritsche HM, Burger M, May M, Gilfrich C. Postoperative Leukocytosis After Robotic-Assisted Radical Prostatectomy Is Not Associated with Perioperative Outcome and Histopathological Findings. J Laparoendosc Adv Surg Tech A. 2015 Oct;25(10):808-13

36.   Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C. Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy–A Prospective Multicenter Study. Urol Int. 2016;96(1):57-64

37.   Wolff I, Brookman-May S, May M. Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke? Curr Opin Urol. 2015 Sep;25(5):418-26

38.   May M, Brookman-May S, Burger M, Koch S, Otto W, Bründl J, Albrecht K, Denzinger S. A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis. Pathol Res Pract. 2015 Sep;211(9):641-5

39.   Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, Herrmann E, Keck B, Wullich B, Mayr R, Fritsche HM, Burger M, Bastian PJ, Seitz C, Brookman-May S, Xylinas E, Shariat SF, Fisch M, May M; PROMETRICS 2011 Research Group. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. World J Urol. 2015 Dec;33(12):1945-50

40.   Aziz A, Kempkensteffen C, May M, Lebentrau S, Burger M, Chun FK, Brookman-May S. Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer. Expert Rev Anticancer Ther. 2015 Jun;15(6):649-66

41.   Brookman-May SD, May M, Wolff I, Zigeuner R, Hutterer GC, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Feciche B, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Zastrow S, Wirth M, Sountoulides P, Shariat S, Waidelich R, Stief C, Gunia S; CORONA Project; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors? Eur Urol. 2015 May;67(5):943-51

42.   Gilfrich C, Brookman-May S, May M, Lebentrau S. [Robot-assisted radical prostatectomy – review of the literature concerning oncological and functional outcome of patients]. Aktuelle Urol. 2014 Nov;45(6):471-85

43.   Gilfrich C, Haferkamp A, Brookman-May S, Ahmed A, Peter J, Eckerl M, Schäfer C, Lebentrau S, May M. [Influence of body mass index on histopathological and intraoperative criteria in a consecutive series of patients after robotic-assisted radical prostatectomy]. Aktuelle Urol. 2014 Nov;45(6):464-9.

44.   Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int. 2016 Feb;117(2):272-9

45.   Vergho D, Burger M, Schrammel M, Brookman-May S, Gierth M, Hoschke B, Lopau K, Gilfrich C, Riedmiller H, Wolff I, May M. Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer. World J Urol. 2015 May;33(5):725-31

46.   Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Gierth M, Pahernik Sh, Protzel C, Roigas J, Gördük M, Lusuardi L, May M, Trinh QD, Fisch M, Chun FK; PROMETRICS 2011 Research Group. Evidence from the ‚PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)‘ study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol. 2015 Mar;22(3):1032-42 – pubmed-gelistet als Kollaborator

47.   May M, Cindolo L, Zigeuner R, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Wolff I, Feciche B, Fenske F, Pichler M, Schips L, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Sountoulides P, Brookman-May S; Members of CORONA project; Young Academic Urologists Renal Cancer Group. Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life. Urol Oncol. 2014 Nov;32(8):1252-8

48.   Froehner M, Novotny V, Wirth MP, Brookman-May S, Aziz A, May M. External validation of a model to predict locoregional failure after radical cystectomy. Cancer. 2014 Nov 15;120(22):3584

49.   May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy. Ann Surg Oncol. 2014 Nov;21(12):4034-40

50.   Zastrow S, Brookman-May S, Cong TA, Jurk S, von Bar I, Novotny V, Wirth M. Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort. World J Urol. 2015 Mar;33(3):381-8

51.   May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series. World J Urol. 2015 Mar;33(3):343-50

52.   Lebentrau S, May M, Maurer O, Schostak M, Lehsnau M, Ecke T, Al-Dumaini S, Hallmann S, Ahmed AM, Braun V, Haferkamp A, Bauer RM, Stief CG, Baumunk D, Hoschke B, Braun HP, Schäfer C, Hipp M, Maurer J, Braun KP, Wolff I, Brookman-May S, Gilfrich C. [Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data]. Urologe A. 2014 May;53(5):715-24

53.   Wolff I, May M, Hoschke B, Brookman-May S. Male circumcision is not associated with an increased prevalence of erectile dysfunction. Asian J Androl. 2014 Jul-Aug;16(4):652-3

54.   Gilfrich C, May M, Braun KP, Lebentrau S, Lehsnau M, Ecke T, Schmailzl KJ, Al-Dumaini S, Hallmann S, Ahmed AM, Maurer J, Karl T, Braun V, Haferkamp A, Brookman-May S, Bauer RM, Stief CG, Hoschke B, Maurer O, Wolff I. Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists. Urol Int. 2014;93(2):160-9

55.   Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F; PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol. 2014 Jul;66(1):156-63

56.   May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer. Clin Genitourin Cancer. 2014 Aug;12(4):278-86

57.   Aziz A, May M, Zigeuner R, Pichler M, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Fenske F, Sountoulides P, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Wieland WF, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Brookman-May S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group. Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database. J Urol. 2014 Feb;191(2):310-5

58.   Brookman-May SD, May M, Shariat SF, Novara G, Zigeuner R, Cindolo L, De Cobelli O, De Nunzio C, Pahernik S, Wirth MP, Longo N, Simonato A, Serni S, Siracusano S, Volpe A, Morgia G, Bertini R, Dalpiaz O, Stief C, Ficarra V; Members of the CORONA-Project; Members of the SATURN-Project; Young Academic Urologists Renal Cancer Group. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma–results from a comprehensive multi-centre database (CORONA/SATURN-Project). BJU Int. 2013 Nov;112(7):909-16

59.   May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG, Brookman-May S; Mitglieder des „CORONA projects“; Projektgruppe „Young Academic Urologists Renal Cancer Group“ der European Association of Urology (EAU). [Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database]. Urologe A. 2014 Feb;53(2):228-35

60.   Brookman-May S, May M, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Feciche B, Coman I, Truss M, Pahernik S, Wirth MP, Zastrow S, Dalpiaz O, Fenske F, Waidelich R, Stief C, Gunia S; Members of the CORONA Project. Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis. Clin Genitourin Cancer. 2013 Dec;11(4):465-70

61.   Rud O, Horstmann M, Aziz A, Fritsche HM, Brookman-May S, Gilfrich C, Burger M, May M. Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic. World J Urol. 2014 Jun;32(3):691-5

62.   Brookman-May S, Langenhuijsen JF, Volpe A, Minervini A, Joniau S, Salagierski M, Roscigno M, Akdogan B, Vandromme A, Rodriguez-Faba O, Marszalek M. Management of localized and locally advanced renal tumors. A contemporary review of current treatment options. Minerva Med. 2013 Jun;104(3):237-59

63.   Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation. World J Urol. 2014 Apr;32(2):365-71

64.   Brookman-May S, Tombal B, Joniau S. Re: Axel Heidenreich, David Pfister. Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care. Eur Urol 2012;62:1201-4. Eur Urol. 2013 Sep;64(3):e62-4

65.   Brookman-May S, Minervini A, Volpe A, Ficarra V, Salagierski M, Marszalek M, Roscigno M, Akdogan B, Vandromme A, Langenhuijsen JF, Rodriguez-Faba O, Joniau S; Renal Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU). Robot-assisted partial nephrectomy in patients with recurrent disease: fiction or fact? BJU Int. 2013 May;111(5):692-4

66.   May M, Aziz A, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Martin Mdel C, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C, Brookman-May S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database. World J Urol. 2013 Oct;31(5):1073-80

67.   Kunath F, Keck B, Bertz S, Brookman-May S, May M, Vergho D, Hartmann A, Riedmiller H, Wullich B, Burger M. Is gender becoming relevant in uro-oncological research? A bibliographical analysis. World J Urol. 2013 Oct;31(5):1065-72

68.   Cindolo L, Chiodini P, Brookman-May S, De Cobelli O, May M, Squillacciotti S, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Wirth MP, Dalpiaz O, Chromecki TF, Shariat SF, Sanchez-Chapado M, Santiago Martin Mdel C, Rocco B, Salzano L, Lotrecchiano G, Berardinelli F, Schips L. Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study. BJU Int. 2013 Sep;112(5):578-84

69.   Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks. Eur J Surg Oncol. 2013 Apr;39(4):372-9

70.   May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S; CORONA and SATURN projects; Young Academic Urologists Renal Cancer Group. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. J Urol. 2013 Aug;190(2):458-63

71.   Hoschke B, Fenske S, Brookman-May S, Spivak I, Gilfrich C, Fritsche HM, Wolff I, May M. [Male circumcision is not associated with an increased prevalence of erectile dysfunction: results of the Cottbus 10,000-men survey]. Urologe A. 2013 Apr;52(4):562-9

72.   May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis. BJU Int. 2013 Aug;112(4):E383-90

73.   Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med. 2012 Dec;9(6):481-9

74.   M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM, Aziz A. Body mass index has no impact on sperm quality but on reproductive hormones levels. Andrologia. 2014 Mar;46(2):106-11

75.   Gunia S, Erbersdobler A, Koch S, Otto W, Staibano S, D’Alterio C, Brookman-May S. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis. Hum Pathol. 2013 May;44(5):712-7

76.   Brookman-May SD, Marszalek M, Joniau S, Minervini A, Langenhujisen JF, Ficarra V, Salagierski M, Roscigno M, Akdogan B, Vandromme A, Rodriguez-Faba O, Volpe A, Renal Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU). Role of carbonic anhydrase IX (CAIX) in patients with renal cell carcinoma: can we currently assess its definitive value in prognosis, prediction to treatment response and diagnosis, and as a therapeutic approach? BJU Int. 9 May 2013.

77.   Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M. Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders‘ grading of penile squamous cell carcinomas. Urol Int. 2013;90(2):207-13

78.   Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol. 2013 Apr;63(4):739-44

79.   Salagierski M, Akdogan B, Brookman-May S, Dobrowolska-Glazar B, Ficarra V, Langenhuijsen JF, Marszalek M, Minervini A, Rodriguez-Faba O, Roscigno M, Vandromme A, Volpe A, Joniau S; Renal Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology. What is the contemporary role of radiofrequency ablation in the management of small renal masses? Are small lesions the radiologist’s tumors? Eur Urol. 2013 Mar;63(3):493-5

80.   Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project. Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series. World J Urol. 2013 Oct;31(5):1309-16

81.   Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V; Members of the CORONA project and the SATURN project. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Eur Urol. 2013 Sep;64(3):472-7

82.   Rud O, Moersler J, Peter J, Waliszewski P, Gilfrich C, Häuser H, Burger M, Fritsche HM, Wieland WF, Ahmed AM, Brookman-May S, May M. Prospective evaluation of interobserver variability of the hydronephrosis index and the renal resistive index as sonographic examination methods for the evaluation of acute hydronephrosis. BJU Int. 2012 Oct;110(8 Pt B):E350-6

83.   Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Eur J Surg Oncol. 2012 Jul;38(7):637-42

84.   May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. J Urol. 2012 Apr;187(4):1210-4

85.   May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol. 2013 Oct;31(7):1141-7

86.   Brookman-May S, Johannsen M, May M, Hoschke B, Gunschera J, Wieland WF, Burger M. Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgery. AJR Am J Roentgenol. 2011 Nov;197(5):1137-45

87.   Brookman-May S, May M, Zigeuner R, Shariat SF, Scherr DS, Chromecki T, Moch H, Wild PJ, Mohamad-Al-Ali B, Cindolo L, Wieland WF, Schips L, De Cobelli O, Rocco B, Santoro L, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Hohenfellner M, Gilfrich C, Wirth MP, Burger M, Pahernik S; CORONA Project (Collaborative Research on Renal Neoplasms Association). Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. J Urol. 2011 Dec;186(6):2175-81

88.   May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M. Gender-dependent cancer-specific survival following radical cystectomy. World J Urol. 2012 Oct;30(5):707-13

89.   Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol. 2012 Jan;61(1):58-64

90.   Brookman-May S, Burger M, Wieland WF, May M. Re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Re: Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30. Eur Urol. 2011 Nov;60(5):e45-6

91.   Brookman-May S, Burger M, Wieland WF, Rössler W, May M, Denzinger S. Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease. Expert Rev Vaccines. 2011 Jun;10(6):837-52

92.   May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011 Sep;45(4):251-7

93.   Brookman-May S, May M, Burger M. Editorial comment from Drs. Brookman-May, May and Burger to „Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy“. Int J Urol. 2011 Apr;18(4):280-1

94.   May M, Brookman-May S, Weißbach L, Herbst H, Gilfrich C, Papadopoulos T, Roigas J, Hofstädter F, Wieland WF, Burger M. Solitary and small (≤3 mm) apical positive surgical margins are related to biochemical recurrence after radical prostatectomy. Int J Urol. 2011 Apr;18(4):282-9

95.   May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]. Urologe A. 2011 Jun;50(6):706-13

96.   May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]. Urologe A. 2011 Jul;50(7):821-9

97.   May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol. 2011 May;59(5):712-8

98.   May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol. 2011 Jul;18(7):2018-25

99.   Brookman-May S, May M, Wieland WF, Lebentrau S, Gunia S, Koch S, Gilfrich C, Roigas J, Hoschke B, Burger M. Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study. World J Urol. 2012 Feb;30(1):97-103

100.                       May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Bastian PJ. [Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]. Urologe A. 2010 Dec;49(12):1508-15

101.                       Brookman-May S, Kendel F, Hoschke B, Wieland WF, Burger M, Rössler W, May M. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma. Scand J Urol Nephrol. 2011 Feb;45(1):5-14

102.                       Brookman-May S, Burger M, Hoschke B, Wieland WF, Kendel F, Gilfrich C, Braun KP, May M. [Association between residual urinary volume and urinary tract infection: prospective trial in 225 male patients]. Urologe A. 2010 Sep;49(9):1163-8

103.                       Rud O, May M, Brookman-May S, Mörsler J, Rotter M, Gilfrich C. [Abscess-forming retroperitoneal actinomycosis after urogynaecological surgery]. Urologe A. 2010 Oct;49(10):1283-6

104.                       Brookman-May S, May M, Gilfrich C, Wieland WF, Burger M. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma? Expert Rev Anticancer Ther. 2010 Jun;10(6):813-23.

105.                       May M, Brookman-May S, Lebentrau S, Gilfrich C, Loy V, Theissig F, Roigas J, Hoschke B, Burger M, Miller K. [Concordance of the Gleason score in prostate multibiopsy and definitive histology]. Aktuelle Urol. 2010 May;41(3):184-92

106.                       May M, Brookman-May S, Hoschke B, Gilfrich C, Kendel F, Baxmann S, Wittke S, Kiessig ST, Miller K, Johannsen M. Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting. Cancer Immunol Immunother. 2010 May;59(5):687-95

107.                       Rud O, May M, Brookman-Amissah S, Moersler J, Greiner A, Gilfrich C. [Retroperitoneal bronchogenic cyst treated by laparoscopic surgery]. Chirurg. 2010 Mar;81(3):243-6

108.                       Braun KP, Braun V, Brookman-Amissah S, May M, Ptok H, Lippert H, Gastinger I. [Treatment of rectal carcinoma: satisfaction of general practitioners with surgical clinics]. Chirurg. 2009 Dec;80(12):1147-51

109.                       May M, Kendel F, Hoschke B, Gilfrich C, Kiessig S, Pflanz S, Seidel M, Brookman-Amissah S. [Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years]. Urologe A. 2009 Sep;48(9):1075-83

110.                       Braun KP, Brookman-Amissah S, May M, Grassmel Y, Hoschke B, Braun V. [The assessment of pathological PSA values by the general practitioner–observation or intervention?]. Aktuelle Urol. 2009 May;40(3):171-4

111.                       Brookman-Amissah S, May M, Albrecht K, Herrmann T, Roigas J, Gilfrich CP, Pflanz S, Gunia S. Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer. World J Urol. 2010 Feb;28(1):103-9

112.                       May M, Brookman-Amissah S, Kendel F, Knoll N, Roigas J, Hoschke B, Miller K, Gilfrich C, Pflanz S, Gralla O. Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma. Int J Urol. 2009 Jul;16(7):616-21

113.                       May M, Brookman-Amissah S, Hoschke B, Gilfrich C, Braun KP, Kendel F. Post-void residual urine as a predictor of urinary tract infection–is there a cutoff value in asymptomatic men? J Urol. 2009 Jun;181(6):2540-4

114.                       May M, Brookman-Amissah S, Roigas J, Hartmann A, Störkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Gunia S. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol. 2010 May;57(5):850-8

115.                       Braun KP, Brookman-Amissah S, Geissler K, Ast D, May M, Ernst H. [Whole-body cryotherapy in patients with inflammatory rheumatic disease. A prospective study]. Med Klin (Munich). 2009 Mar 15;104(3):192-6

116.                       May M, Brookman-Amissah S, Pflanz S, Roigas J, Hoschke B, Kendel F. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol. 2009 Aug;82(981):724-31

117.                       May M, Brookman-Amissah S, Pflanz S, Knoll N, Roigas J, Gunia S, Hoschke B, Kendel F. [Value of the postoperative Störkel score. Predict disease-free survival of patients with surgically resected renal cell carcinoma]. Urologe A. 2009 Mar;48(3):284-90

118.                       Brookman-Amissah S, Kendel F, Spivak I, Pflanz S, Roigas J, Klotz T, May M. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma. BJU Int. 2009 May;103(10):1375-80

119.                       Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma. Scand J Urol Nephrol. 2008;42(6):507-13

120.                       May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view. Urol Oncol. 2010 May-Jun;28(3):274-9

121.                       Braun KP, Brookman-Amissah S, May M, Grassmel Y, Heintze C, Hoschke B, Braun V. [The significance of rebiopsy in the diagnosis of prostate cancer]. Urologe A. 2009 Feb;48(2):163-9

122.                       May M, Kalisch R, Hoschke B, Juretzek T, Wagenlehner F, Brookman-Amissah S, Spivak I, Braun KP, Bär W, Helke C. [Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?]. Urologe A. 2008 Jul;47(7):846-52

123.                       Ebert AK, Brookman-Amissah S, Rösch WH. [Urological manifestations of Down syndrome: significance and long-term complications — our own patient cohort with an overview]. Urologe A. 2008 Mar;47(3):337-41

124.                       May M, Fuhrer S, Braun KP, Brookman-Amissah S, Richter W, Hoschke B, Vogler H, Siegsmund M. Results from three municipal hospitals regarding radical cystectomy on elderly patients.